O	O	0	8	Distinct	Distinct	B-NP	JJ	O	2	NMOD	O
O	O	9	19	mechanisms	mechanism	I-NP	NNS	O	0	ROOT	O
O	O	20	23	for	for	B-PP	IN	O	2	NMOD	O
T20	B-Entity	24	25	N	N	B-NP	NN	O	3	PMOD	O
T20	I-Entity	25	26	-	-	I-NP	HYPH	O	4	NMOD	O
T20	I-Entity	26	40	acetylcysteine	acetylcysteine	I-NP	NN	O	7	NMOD	O
O	O	41	51	inhibition	inhibition	I-NP	NN	O	5	OBJ	O
O	O	52	54	of	of	B-PP	IN	O	7	NMOD	O
O	O	55	63	cytokine	cytokine	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	63	64	-	-	O	HYPH	O	9	P	O
O	O	64	71	induced	induce	B-NP	VBN	O	9	AMOD	O
T1	B-Protein	72	73	E	E	I-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Protein	73	74	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T1	I-Protein	74	82	selectin	selectin	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	83	86	and	and	I-NP	CC	O	19	NMOD	O
T2	B-Protein	87	91	VCAM	VCAM	I-NP	NN	B-protein	19	NMOD	B-protein
T2	I-Protein	91	92	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T2	I-Protein	92	93	1	1	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	94	104	expression	expression	I-NP	NN	O	8	PMOD	O
O	O	104	105	.	.	O	.	O	2	P	O

O	O	107	109	We	We	B-NP	PRP	O	2	SUB	O
O	O	110	114	have	have	B-VP	VBP	O	0	ROOT	O
O	O	115	123	examined	examine	I-VP	VBN	O	2	VC	O
O	O	124	127	the	the	B-NP	DT	O	5	NMOD	O
O	O	128	135	effects	effect	I-NP	NNS	O	3	OBJ	O
O	O	136	138	of	of	B-PP	IN	O	5	NMOD	O
T21	B-Entity	139	140	N	N	B-NP	NN	O	6	PMOD	O
T21	I-Entity	140	141	-	-	B-NP	HYPH	O	7	NMOD	O
T21	I-Entity	141	147	acetyl	acetyl	I-NP	NN	O	8	OBJ	O
T21	I-Entity	147	148	-	-	B-NP	HYPH	O	9	NMOD	O
T21	I-Entity	148	149	L	L	I-NP	NN	O	10	PMOD	O
T21	I-Entity	149	150	-	-	O	HYPH	O	11	NMOD	O
T21	I-Entity	150	158	cysteine	cysteine	B-NP	NN	O	12	PMOD	O
O	O	159	160	(	(	O	(	O	16	DEP	O
T22	B-Entity	160	163	NAC	NAC	B-NP	NN	O	16	DEP	O
O	O	163	164	)	)	O	)	O	13	NMOD	O
O	O	164	165	,	,	O	,	O	13	P	O
O	O	166	167	a	a	B-NP	DT	O	17	PMOD	O
O	O	168	172	well	well	I-NP	RB	O	20	AMOD	O
O	O	172	173	-	-	I-NP	HYPH	O	21	P	O
O	O	173	186	characterized	characterize	I-NP	VBN	O	18	NMOD	O
O	O	186	187	,	,	I-NP	,	O	21	VMOD	O
T23	B-Entity	188	193	thiol	thiol	I-NP	NN	O	22	OBJ	O
T23	I-Entity	193	194	-	-	I-NP	HYPH	O	23	P	O
T23	I-Entity	194	204	containing	contain	B-VP	VBG	O	23	NMOD	O
T23	I-Entity	205	216	antioxidant	antioxidant	B-NP	NN	O	25	OBJ	O
O	O	216	217	,	,	O	,	O	23	P	O
O	O	218	220	on	on	B-PP	IN	O	23	NMOD	O
O	O	221	228	agonist	agonist	B-NP	NN	O	34	NMOD	O
O	O	228	229	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	229	236	induced	induce	I-NP	VBN	O	34	NMOD	O
O	O	237	246	monocytic	monocytic	I-NP	JJ	O	34	NMOD	O
O	O	247	251	cell	cell	I-NP	NN	O	34	NMOD	O
O	O	252	260	adhesion	adhesion	I-NP	NN	O	28	PMOD	O
O	O	261	263	to	to	B-PP	TO	O	34	NMOD	O
O	O	264	275	endothelial	endothelial	B-NP	JJ	B-cell_type	37	NMOD	B-cell_type
O	O	276	281	cells	cell	I-NP	NNS	I-cell_type	35	PMOD	I-cell_type
O	O	282	283	(	(	O	(	O	40	DEP	O
O	O	283	285	EC	EC	B-NP	NN	B-cell_type	40	DEP	B-cell_type
O	O	285	286	)	)	O	)	O	37	NMOD	O
O	O	286	287	.	.	O	.	O	2	P	O

T24	B-Entity	288	291	NAC	NAC	B-NP	NN	O	2	SUB	O
O	O	292	301	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	302	313	interleukin	interleukin	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	313	314	-	-	B-NP	HYPH	O	2	P	O
O	O	314	315	1	1	I-NP	CD	O	2	VMOD	O
O	O	316	317	(	(	O	(	O	11	DEP	O
T3	B-Protein	317	319	IL	IL	B-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	319	320	-	-	O	HYPH	I-protein	10	P	I-protein
T3	I-Protein	320	321	1	1	B-NP	CD	I-protein	10	NMOD	I-protein
T3	I-Protein	322	326	beta	beta	B-NP	SYM	I-protein	11	DEP	I-protein
O	O	326	327	)	)	O	)	O	5	NMOD	O
O	O	327	328	-	-	B-NP	HYPH	O	5	P	O
O	O	328	335	induced	induce	B-VP	VBN	O	5	NMOD	O
O	O	335	336	,	,	O	,	O	13	P	O
O	O	337	340	but	but	O	CC	O	14	PMOD	O
O	O	341	344	not	not	O	RB	O	15	DEP	O
O	O	345	350	basal	basal	B-ADJP	JJ	O	15	PRD	O
O	O	350	351	,	,	O	,	O	19	P	O
O	O	352	360	adhesion	adhesion	B-NP	NN	O	17	AMOD	O
O	O	361	365	with	with	B-PP	IN	O	19	NMOD	O
O	O	366	368	50	50	B-NP	CD	O	22	AMOD	O
O	O	368	369	%	%	I-NP	NN	O	23	NMOD	O
O	O	370	380	inhibition	inhibition	I-NP	NN	O	20	PMOD	O
O	O	381	383	at	at	B-PP	IN	O	23	NMOD	O
O	O	384	397	approximately	approximately	B-NP	RB	O	27	NMOD	O
O	O	398	400	20	20	I-NP	CD	O	25	AMOD	O
O	O	401	403	mM	mM	I-NP	NN	O	24	PMOD	O
O	O	403	404	.	.	O	.	O	19	P	O

O	O	405	414	Monocytic	Monocytic	B-NP	JJ	O	3	NMOD	O
O	O	415	419	cell	cell	I-NP	NN	O	3	NMOD	O
O	O	420	428	adhesion	adhesion	I-NP	NN	O	40	SUB	O
O	O	429	431	to	to	B-PP	TO	O	3	NMOD	O
O	O	432	434	EC	EC	B-NP	NN	B-cell_type	4	PMOD	B-cell_type
O	O	435	437	in	in	B-PP	IN	O	3	NMOD	O
O	O	438	446	response	response	B-NP	NN	O	6	PMOD	O
O	O	447	449	to	to	B-PP	TO	O	7	NMOD	O
T4	B-Protein	450	455	tumor	tumor	B-NP	NN	B-protein	13	NMOD	B-protein
T4	I-Protein	456	464	necrosis	necrosis	I-NP	NN	I-protein	13	NMOD	I-protein
T4	I-Protein	465	471	factor	factor	I-NP	NN	I-protein	13	NMOD	I-protein
T4	I-Protein	471	472	-	-	O	HYPH	I-protein	13	P	I-protein
T4	I-Protein	472	477	alpha	alpha	B-NP	SYM	I-protein	36	NMOD	I-protein
O	O	478	479	(	(	O	(	O	18	DEP	O
T5	B-Protein	479	482	TNF	TNF	B-NP	NN	B-protein	17	NMOD	B-protein
T5	I-Protein	482	483	-	-	O	HYPH	I-protein	17	P	I-protein
T5	I-Protein	483	488	alpha	alpha	B-NP	SYM	I-protein	18	DEP	I-protein
O	O	488	489	)	)	O	)	O	13	NMOD	O
O	O	489	490	,	,	O	,	O	36	P	O
O	O	491	509	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	36	NMOD	O
O	O	510	511	(	(	O	(	O	23	DEP	O
O	O	511	514	LPS	LPS	B-NP	NN	O	23	DEP	O
O	O	514	515	)	)	O	)	O	20	NMOD	O
O	O	515	516	,	,	O	,	O	36	P	O
T6	B-Protein	517	522	alpha	alpha	O	SYM	O	36	NMOD	O
T6	I-Protein	522	523	-	-	O	HYPH	O	36	NMOD	O
T6	I-Protein	523	531	thrombin	thrombin	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	531	532	,	,	O	,	O	30	P	O
O	O	533	535	or	or	O	CC	O	30	NMOD	O
O	O	536	543	phorbol	phorbol	B-NP	NN	O	36	NMOD	O
O	O	544	546	12	12	I-NP	CD	O	30	NMOD	O
O	O	546	547	-	-	O	HYPH	O	36	NMOD	O
O	O	547	556	myristate	myristate	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	557	559	13	13	I-NP	CD	I-protein	33	NMOD	I-protein
O	O	559	560	-	-	O	HYPH	O	33	P	O
O	O	560	567	acetate	acetate	B-NP	NN	O	8	PMOD	O
O	O	568	569	(	(	O	(	O	39	DEP	O
O	O	569	572	PMA	PMA	B-NP	NN	O	39	DEP	O
O	O	572	573	)	)	O	)	O	36	NMOD	O
O	O	574	577	was	be	B-VP	VBD	O	0	ROOT	O
O	O	578	587	similarly	similarly	I-VP	RB	O	40	VMOD	O
O	O	588	597	inhibited	inhibit	I-VP	VBN	O	40	VC	O
O	O	598	600	by	by	B-PP	IN	O	42	VMOD	O
T25	B-Entity	601	604	NAC	NAC	B-NP	NN	O	43	PMOD	O
O	O	604	605	.	.	O	.	O	40	P	O

O	O	606	612	Unlike	Unlike	B-PP	IN	O	22	VMOD	O
O	O	613	622	published	publish	B-NP	VBN	O	3	NMOD	O
O	O	623	630	studies	study	I-NP	NNS	O	1	PMOD	O
O	O	631	635	with	with	B-PP	IN	O	3	NMOD	O
O	O	636	662	pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	B-NP	NN	O	4	PMOD	O
O	O	662	663	,	,	O	,	O	5	P	O
O	O	664	669	which	which	B-NP	WDT	O	5	NMOD	O
O	O	670	682	specifically	specifically	B-ADVP	RB	O	9	VMOD	O
O	O	683	692	inhibited	inhibit	B-VP	VBD	O	7	SBAR	O
T7	B-Protein	693	701	vascular	vascular	B-NP	JJ	B-protein	13	NMOD	B-protein
T7	I-Protein	702	706	cell	cell	I-NP	NN	I-protein	13	NMOD	I-protein
T7	I-Protein	707	715	adhesion	adhesion	I-NP	NN	I-protein	13	NMOD	I-protein
T7	I-Protein	716	724	molecule	molecule	I-NP	NN	I-protein	9	OBJ	I-protein
T7	I-Protein	725	726	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	727	728	(	(	O	(	O	19	DEP	O
T8	B-Protein	728	732	VCAM	VCAM	B-NP	NN	B-protein	17	NMOD	B-protein
T8	I-Protein	732	733	-	-	B-NP	HYPH	I-protein	19	DEP	I-protein
T8	I-Protein	733	734	1	1	I-NP	CD	I-protein	17	NMOD	I-protein
O	O	734	735	)	)	O	)	O	13	NMOD	O
O	O	735	736	,	,	O	,	O	22	P	O
T26	B-Entity	737	740	NAC	NAC	B-NP	NN	O	22	SUB	O
O	O	741	750	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
T9	B-Protein	751	753	IL	IL	B-NP	NN	B-protein	26	NMOD	B-protein
T9	I-Protein	753	754	-	-	B-NP	HYPH	I-protein	25	P	I-protein
T9	I-Protein	754	755	1	1	I-NP	CD	I-protein	26	NMOD	I-protein
T9	I-Protein	756	760	beta	beta	O	SYM	I-protein	33	NMOD	I-protein
O	O	760	761	-	-	O	HYPH	B-RNA	29	NMOD	B-RNA
O	O	761	768	induced	induce	B-VP	VBN	I-RNA	29	NMOD	I-RNA
O	O	769	773	mRNA	mRNA	B-NP	NN	I-RNA	33	NMOD	I-RNA
O	O	774	777	and	and	O	CC	O	33	NMOD	O
O	O	778	782	cell	cell	B-NP	NN	O	33	NMOD	O
O	O	783	790	surface	surface	I-NP	NN	O	33	NMOD	O
O	O	791	801	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	802	804	of	of	B-PP	IN	O	33	NMOD	O
O	O	805	809	both	both	O	CC	O	41	NMOD	O
T10	B-Protein	810	811	E	E	B-NP	NN	B-protein	38	NMOD	B-protein
T10	I-Protein	811	812	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
T10	I-Protein	812	820	selectin	selectin	I-NP	NN	I-protein	41	NMOD	I-protein
O	O	821	824	and	and	I-NP	CC	O	41	NMOD	O
T11	B-Protein	825	829	VCAM	VCAM	I-NP	NN	B-protein	41	NMOD	B-protein
T11	I-Protein	829	830	-	-	B-NP	HYPH	I-protein	34	PMOD	I-protein
T11	I-Protein	830	831	1	1	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	831	832	.	.	O	.	O	22	P	O

T27	B-Entity	833	836	NAC	NAC	B-NP	NN	O	2	SUB	O
O	O	837	840	had	have	B-VP	VBD	O	0	ROOT	O
O	O	841	843	no	no	B-NP	DT	O	4	NMOD	O
O	O	844	850	effect	effect	I-NP	NN	O	2	OBJ	O
O	O	851	853	on	on	B-PP	IN	O	2	VMOD	O
O	O	854	857	the	the	B-NP	DT	O	9	NMOD	O
O	O	858	862	half	half	I-NP	JJ	O	9	NMOD	O
O	O	862	863	-	-	I-NP	HYPH	O	9	NMOD	O
O	O	863	867	life	life	I-NP	NN	O	18	NMOD	O
O	O	868	870	of	of	B-PP	IN	O	9	NMOD	O
T12	B-Protein	871	872	E	E	B-NP	NN	B-protein	13	NMOD	B-protein
T12	I-Protein	872	873	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T12	I-Protein	873	881	selectin	selectin	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	882	884	or	or	I-NP	CC	O	15	NMOD	O
T13	B-Protein	885	889	VCAM	VCAM	I-NP	NN	B-protein	10	PMOD	B-protein
T13	I-Protein	889	890	-	-	B-NP	HYPH	O	18	NMOD	O
T13	I-Protein	890	891	1	1	I-NP	CD	B-RNA	18	NMOD	B-RNA
O	O	892	896	mRNA	mRNA	I-NP	NN	I-RNA	5	PMOD	I-RNA
O	O	896	897	.	.	O	.	O	2	P	O

O	O	898	906	Although	Although	B-SBAR	IN	O	56	VMOD	O
T28	B-Entity	907	910	NAC	NAC	B-NP	NN	O	3	SUB	O
O	O	911	918	reduced	reduce	B-VP	VBD	O	1	SBAR	O
T29	B-Entity	919	926	nuclear	nuclear	B-NP	JJ	B-protein	8	NMOD	B-protein
T29	I-Entity	927	933	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T29	I-Entity	933	934	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T29	I-Entity	934	939	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T29	I-Entity	940	941	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	942	943	(	(	O	(	O	14	DEP	O
T30	B-Entity	943	945	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T30	I-Entity	945	946	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T30	I-Entity	946	951	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
T30	I-Entity	952	953	B	B	I-NP	NN	I-protein	14	DEP	I-protein
O	O	953	954	)	)	O	)	O	8	NMOD	O
O	O	955	965	activation	activation	B-NP	NN	O	3	OBJ	O
O	O	966	968	in	in	B-PP	IN	O	15	NMOD	O
O	O	969	971	EC	EC	B-NP	NN	B-cell_type	16	PMOD	B-cell_type
O	O	972	974	as	as	B-SBAR	IN	O	3	VMOD	O
O	O	975	983	measured	measure	B-VP	VBN	O	18	SBAR	O
O	O	984	986	by	by	B-PP	IN	O	19	VMOD	O
O	O	987	990	gel	gel	B-NP	NN	O	24	NMOD	O
O	O	990	991	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	991	996	shift	shift	I-NP	NN	O	24	NMOD	O
O	O	997	1003	assays	assay	I-NP	NNS	O	20	PMOD	O
O	O	1004	1009	using	use	B-VP	VBG	O	24	NMOD	O
O	O	1010	1012	an	an	B-NP	DT	O	28	NMOD	O
T31	B-Entity	1013	1028	oligonucleotide	oligonucleotide	I-NP	NN	B-DNA	28	NMOD	B-DNA
T31	I-Entity	1029	1034	probe	probe	I-NP	NN	I-DNA	25	OBJ	I-DNA
O	O	1035	1048	corresponding	correspond	B-VP	VBG	O	28	NMOD	O
O	O	1049	1051	to	to	B-PP	TO	O	29	VMOD	O
O	O	1052	1055	the	the	B-NP	DT	O	38	NMOD	O
O	O	1056	1065	consensus	consensus	I-NP	NN	B-DNA	38	NMOD	B-DNA
T32,T33	B-Entity,B-Entity	1066	1068	NF	NF	I-NP	NN	I-DNA	38	NMOD	I-DNA
T32,T33	I-Entity,I-Entity	1068	1069	-	-	B-NP	HYPH	I-DNA	38	NMOD	I-DNA
T32,T33	I-Entity,I-Entity	1069	1074	kappa	kappa	I-NP	NN	I-DNA	38	NMOD	I-DNA
T32,T33	I-Entity,I-Entity	1075	1076	B	B	I-NP	NN	I-DNA	38	NMOD	I-DNA
T32	I-Entity	1077	1084	binding	binding	I-NP	NN	I-DNA	38	NMOD	I-DNA
T32	I-Entity	1085	1090	sites	site	I-NP	NNS	I-DNA	30	PMOD	I-DNA
O	O	1091	1093	of	of	B-PP	IN	O	38	NMOD	O
O	O	1094	1097	the	the	B-NP	DT	O	44	NMOD	O
T14	B-Protein	1098	1102	VCAM	VCAM	I-NP	NN	B-protein	44	NMOD	B-protein
T14	I-Protein	1102	1103	-	-	B-NP	HYPH	O	44	NMOD	O
T14	I-Protein	1103	1104	1	1	I-NP	CD	O	44	NMOD	O
O	O	1105	1109	gene	gene	I-NP	NN	O	39	PMOD	O
O	O	1110	1111	(	(	O	(	O	52	DEP	O
T34	B-Entity	1111	1115	VCAM	VCAM	B-NP	NN	B-protein	51	NMOD	B-protein
T34	I-Entity	1115	1116	-	-	B-NP	HYPH	O	51	P	O
T34,T35	I-Entity,B-Entity	1116	1118	NF	NF	I-NP	NN	B-protein	51	NMOD	B-protein
T34,T35	I-Entity,I-Entity	1118	1119	-	-	B-NP	HYPH	I-protein	51	NMOD	I-protein
T34,T35	I-Entity,I-Entity	1119	1124	kappa	kappa	I-NP	NN	I-protein	51	NMOD	I-protein
T34,T35	I-Entity,I-Entity	1125	1126	B	B	I-NP	NN	I-protein	52	DEP	I-protein
O	O	1126	1127	)	)	O	)	O	44	NMOD	O
O	O	1127	1128	,	,	O	,	O	56	P	O
O	O	1129	1132	the	the	B-NP	DT	O	55	NMOD	O
O	O	1133	1144	antioxidant	antioxidant	I-NP	NN	O	56	SUB	O
O	O	1145	1148	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1149	1151	no	no	B-NP	DT	O	59	NMOD	O
O	O	1152	1163	appreciable	appreciable	I-NP	JJ	O	59	NMOD	O
O	O	1164	1170	effect	effect	I-NP	NN	O	56	OBJ	O
O	O	1171	1175	when	when	B-ADVP	WRB	O	56	VMOD	O
O	O	1176	1178	an	an	B-NP	DT	O	62	NMOD	O
O	O	1179	1187	oligomer	oligomer	I-NP	NN	O	89	SUB	O
O	O	1188	1201	corresponding	correspond	B-VP	VBG	O	62	NMOD	O
O	O	1202	1204	to	to	B-PP	TO	O	63	VMOD	O
O	O	1205	1208	the	the	B-NP	DT	O	72	NMOD	O
T36	B-Entity	1209	1218	consensus	consensus	I-NP	NN	B-DNA	72	NMOD	B-DNA
T36,T37	I-Entity,B-Entity	1219	1221	NF	NF	I-NP	NN	I-DNA	72	NMOD	I-DNA
T36,T37	I-Entity,I-Entity	1221	1222	-	-	B-NP	HYPH	I-DNA	72	NMOD	I-DNA
T36,T37	I-Entity,I-Entity	1222	1227	kappa	kappa	I-NP	NN	I-DNA	72	NMOD	I-DNA
T36,T37	I-Entity,I-Entity	1228	1229	B	B	I-NP	NN	I-DNA	72	NMOD	I-DNA
T36	I-Entity	1230	1237	binding	binding	I-NP	NN	I-DNA	72	NMOD	I-DNA
T36	I-Entity	1238	1242	site	site	I-NP	NN	I-DNA	64	PMOD	I-DNA
O	O	1243	1245	of	of	B-PP	IN	O	72	NMOD	O
O	O	1246	1249	the	the	B-NP	DT	O	78	NMOD	O
T15	B-Protein	1250	1251	E	E	I-NP	NN	B-DNA	78	NMOD	B-DNA
T15	I-Protein	1251	1252	-	-	B-NP	HYPH	I-DNA	78	NMOD	I-DNA
T15	I-Protein	1252	1260	selectin	selectin	I-NP	NN	I-DNA	78	NMOD	I-DNA
O	O	1261	1265	gene	gene	I-NP	NN	I-DNA	73	PMOD	I-DNA
O	O	1266	1267	(	(	O	(	O	88	DEP	O
T16,T38	B-Protein,B-Entity	1267	1268	E	E	B-NP	NN	B-protein	82	NMOD	B-protein
T16,T38	I-Protein,I-Entity	1268	1269	-	-	B-NP	HYPH	I-protein	82	P	I-protein
T16,T38	I-Protein,I-Entity	1269	1277	selectin	selectin	I-NP	NN	I-protein	87	NMOD	I-protein
T38	I-Entity	1277	1278	-	-	B-NP	HYPH	O	87	P	O
T38,T39	I-Entity,B-Entity	1278	1280	NF	NF	I-NP	NN	B-protein	87	NMOD	B-protein
T38,T39	I-Entity,I-Entity	1280	1281	-	-	B-NP	HYPH	I-protein	87	NMOD	I-protein
T38,T39	I-Entity,I-Entity	1281	1286	kappa	kappa	I-NP	NN	I-protein	87	NMOD	I-protein
T38,T39	I-Entity,I-Entity	1287	1288	B	B	I-NP	NN	I-protein	88	DEP	I-protein
O	O	1288	1289	)	)	O	)	O	62	NMOD	O
O	O	1290	1293	was	be	B-VP	VBD	O	60	SBAR	O
O	O	1294	1298	used	use	I-VP	VBN	O	89	VC	O
O	O	1298	1299	.	.	O	.	O	56	P	O

O	O	1300	1307	Because	Because	B-SBAR	IN	O	15	VMOD	O
T40	B-Entity	1308	1310	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T40	I-Entity	1310	1311	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T40	I-Entity	1311	1316	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T40	I-Entity	1317	1318	B	B	I-NP	NN	I-protein	6	SUB	I-protein
O	O	1319	1322	has	have	B-VP	VBZ	O	1	SBAR	O
O	O	1323	1327	been	be	I-VP	VBN	O	6	VC	O
O	O	1328	1336	reported	report	I-VP	VBN	O	7	VC	O
O	O	1337	1339	to	to	I-VP	TO	O	10	VMOD	O
O	O	1340	1342	be	be	I-VP	VB	O	8	VMOD	O
O	O	1343	1348	redox	redox	B-NP	NN	O	10	PRD	O
O	O	1349	1358	sensitive	sensitive	B-ADJP	JJ	O	11	AMOD	O
O	O	1358	1359	,	,	O	,	O	15	P	O
O	O	1360	1362	we	we	B-NP	PRP	O	15	SUB	O
O	O	1363	1370	studied	study	B-VP	VBD	O	0	ROOT	O
O	O	1371	1374	the	the	B-NP	DT	O	17	NMOD	O
O	O	1375	1382	effects	effect	I-NP	NNS	O	15	OBJ	O
O	O	1383	1385	of	of	B-PP	IN	O	17	NMOD	O
T41	B-Entity	1386	1389	NAC	NAC	B-NP	NN	O	18	PMOD	O
O	O	1390	1392	on	on	B-PP	IN	O	17	NMOD	O
O	O	1393	1396	the	the	B-NP	DT	O	24	NMOD	O
O	O	1397	1399	EC	EC	I-NP	NNP	B-cell_type	24	NMOD	B-cell_type
O	O	1400	1405	redox	redox	I-NP	NN	O	24	NMOD	O
O	O	1406	1417	environment	environment	I-NP	NN	O	20	PMOD	O
O	O	1417	1418	.	.	O	.	O	15	P	O

T42	B-Entity	1419	1422	NAC	NAC	B-NP	NN	O	2	SUB	O
O	O	1423	1429	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	1430	1432	an	an	B-NP	DT	O	6	NMOD	O
O	O	1433	1441	expected	expect	I-NP	VBN	O	5	AMOD	O
O	O	1442	1450	dramatic	dramatic	I-NP	JJ	O	6	NMOD	O
O	O	1451	1459	increase	increase	I-NP	NN	O	2	OBJ	O
O	O	1460	1462	in	in	B-PP	IN	O	6	NMOD	O
O	O	1463	1466	the	the	B-NP	DT	O	14	NMOD	O
T43	B-Entity	1467	1474	reduced	reduce	I-NP	VBN	O	10	NMOD	O
T43	I-Entity	1475	1486	glutathione	glutathione	I-NP	NN	O	14	NMOD	O
O	O	1487	1488	(	(	O	(	O	13	DEP	O
T44	B-Entity	1488	1491	GSH	GSH	B-NP	NN	O	13	DEP	O
O	O	1491	1492	)	)	O	)	O	10	NMOD	O
O	O	1493	1499	levels	level	B-NP	NNS	O	7	PMOD	O
O	O	1500	1502	in	in	B-PP	IN	O	14	NMOD	O
O	O	1503	1505	EC	EC	B-NP	NN	B-cell_type	15	PMOD	B-cell_type
O	O	1505	1506	.	.	O	.	O	2	P	O

O	O	1507	1509	In	In	B-NP	FW	O	2	AMOD	O
O	O	1510	1515	vitro	vitro	I-NP	FW	O	3	NMOD	O
O	O	1516	1523	studies	study	I-NP	NNS	O	4	SUB	O
O	O	1524	1536	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	1537	1541	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1542	1549	whereas	whereas	B-SBAR	IN	O	59	VMOD	O
O	O	1550	1553	the	the	B-NP	DT	O	9	NMOD	O
O	O	1554	1561	binding	binding	I-NP	NN	O	9	NMOD	O
O	O	1562	1570	affinity	affinity	I-NP	NN	O	24	SUB	O
O	O	1571	1573	of	of	B-PP	IN	O	9	NMOD	O
T45	B-Entity	1574	1576	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T45	I-Entity	1576	1577	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T45	I-Entity	1577	1582	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T45	I-Entity	1583	1584	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	1585	1587	to	to	B-PP	TO	O	9	NMOD	O
O	O	1588	1591	the	the	B-NP	DT	O	23	NMOD	O
O	O	1592	1596	VCAM	VCAM	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	1596	1597	-	-	B-NP	HYPH	O	23	NMOD	O
T46	B-Entity	1597	1599	NF	NF	I-NP	NN	B-protein	23	NMOD	B-protein
T46	I-Entity	1599	1600	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T46	I-Entity	1600	1605	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T46	I-Entity	1606	1607	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1608	1616	oligomer	oligomer	I-NP	NN	O	15	PMOD	O
O	O	1617	1623	peaked	peak	B-VP	VBD	O	6	SBAR	O
O	O	1624	1626	at	at	B-PP	IN	O	24	VMOD	O
O	O	1627	1628	a	a	B-NP	DT	O	27	NMOD	O
T47	B-Entity	1629	1632	GSH	GSH	I-NP	NN	O	32	NMOD	O
O	O	1632	1633	-	-	B-ADJP	HYPH	O	27	P	O
O	O	1633	1635	to	to	B-PP	TO	O	31	VMOD	O
O	O	1635	1636	-	-	B-NP	HYPH	O	31	P	O
T48	B-Entity	1636	1644	oxidized	oxidize	I-NP	VBN	O	32	NMOD	O
T48	I-Entity	1645	1656	glutathione	glutathione	I-NP	NN	O	36	NMOD	O
O	O	1657	1658	(	(	O	(	O	35	DEP	O
T49	B-Entity	1658	1662	GSSG	GSSG	B-NP	NN	O	35	DEP	O
O	O	1662	1663	)	)	O	)	O	32	NMOD	O
O	O	1664	1669	ratio	ratio	B-NP	NN	O	25	PMOD	O
O	O	1670	1672	of	of	B-PP	IN	O	36	NMOD	O
O	O	1673	1686	approximately	approximately	B-NP	RB	O	39	NMOD	O
O	O	1687	1690	200	200	I-NP	CD	O	37	PMOD	O
O	O	1691	1694	and	and	O	CC	O	24	VMOD	O
O	O	1695	1704	decreased	decrease	B-VP	VBD	O	24	VMOD	O
O	O	1705	1707	at	at	B-PP	IN	O	41	VMOD	O
O	O	1708	1714	higher	high	B-NP	JJR	O	44	NMOD	O
O	O	1715	1721	ratios	ratio	I-NP	NNS	O	42	PMOD	O
O	O	1721	1722	,	,	O	,	O	59	P	O
O	O	1723	1726	the	the	B-NP	DT	O	47	NMOD	O
O	O	1727	1734	binding	binding	I-NP	NN	O	59	SUB	O
O	O	1735	1737	to	to	B-PP	TO	O	47	NMOD	O
O	O	1738	1741	the	the	B-NP	DT	O	52	NMOD	O
T17	B-Protein	1742	1743	E	E	I-NP	NN	B-protein	52	NMOD	B-protein
T17	I-Protein	1743	1744	-	-	B-NP	HYPH	I-protein	52	P	I-protein
T17	I-Protein	1744	1752	selectin	selectin	I-NP	NN	I-protein	58	NMOD	I-protein
O	O	1752	1753	-	-	B-NP	HYPH	O	58	NMOD	O
T50	B-Entity	1753	1755	NF	NF	I-NP	NN	B-protein	58	NMOD	B-protein
T50	I-Entity	1755	1756	-	-	B-NP	HYPH	I-protein	58	NMOD	I-protein
T50	I-Entity	1756	1761	kappa	kappa	I-NP	NN	I-protein	58	NMOD	I-protein
T50	I-Entity	1762	1763	B	B	I-NP	NN	I-protein	58	NMOD	I-protein
O	O	1764	1772	oligomer	oligomer	I-NP	NN	O	48	PMOD	O
O	O	1773	1781	appeared	appear	B-VP	VBD	O	5	SBAR	O
O	O	1782	1792	relatively	relatively	B-ADJP	RB	O	61	AMOD	O
O	O	1793	1803	unaffected	unaffected	I-ADJP	JJ	O	59	PRD	O
O	O	1804	1808	even	even	B-ADVP	RB	O	63	PMOD	O
O	O	1809	1811	at	at	B-PP	IN	O	61	AMOD	O
O	O	1812	1818	ratios	ratio	B-NP	NNS	O	73	NMOD	O
O	O	1819	1820	>	>	B-VP	SYM	O	64	NMOD	O
O	O	1821	1824	400	400	B-NP	CD	O	65	AMOD	O
O	O	1824	1825	,	,	O	,	O	73	P	O
O	O	1826	1827	i	i	B-NP	NN	O	73	NMOD	O
O	O	1827	1828	.	.	O	.	O	73	P	O
O	O	1828	1829	e	e	B-NP	NN	O	71	NMOD	O
O	O	1829	1830	.	.	I-NP	NN	O	73	NMOD	O
O	O	1830	1831	,	,	O	,	O	73	P	O
O	O	1832	1837	those	those	B-NP	DT	O	63	PMOD	O
O	O	1838	1846	achieved	achieve	B-VP	VBN	O	73	NMOD	O
O	O	1847	1849	in	in	B-PP	IN	O	74	VMOD	O
O	O	1850	1852	EC	EC	B-NP	NNS	B-cell_type	75	PMOD	B-cell_type
O	O	1853	1860	treated	treat	B-VP	VBN	O	76	NMOD	O
O	O	1861	1865	with	with	B-PP	IN	O	77	VMOD	O
O	O	1866	1868	40	40	B-NP	CD	O	80	AMOD	O
O	O	1869	1871	mM	mM	I-NP	NN	O	81	NMOD	O
T51	B-Entity	1872	1875	NAC	NAC	I-NP	NN	O	78	PMOD	O
O	O	1875	1876	.	.	O	.	O	4	P	O

O	O	1877	1882	These	These	B-NP	DT	O	2	NMOD	O
O	O	1883	1890	results	result	I-NP	NNS	O	3	SUB	O
O	O	1891	1898	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1899	1903	that	that	B-SBAR	IN	O	3	VMOD	O
T52	B-Entity	1904	1906	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T52	I-Entity	1906	1907	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T52	I-Entity	1907	1912	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T52	I-Entity	1913	1914	B	B	I-NP	NN	I-protein	24	SUB	I-protein
O	O	1915	1922	binding	bind	B-VP	VBG	O	8	NMOD	O
O	O	1923	1925	to	to	B-PP	TO	O	9	VMOD	O
O	O	1926	1929	its	its	B-NP	PRP$	O	13	NMOD	O
O	O	1930	1939	consensus	consensus	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	1940	1949	sequences	sequence	I-NP	NNS	I-DNA	10	PMOD	I-DNA
O	O	1950	1952	in	in	B-PP	IN	O	13	NMOD	O
O	O	1953	1956	the	the	B-NP	DT	O	23	NMOD	O
T18	B-Protein	1957	1961	VCAM	VCAM	I-NP	NN	B-protein	23	NMOD	B-protein
T18	I-Protein	1961	1962	-	-	B-NP	HYPH	O	23	NMOD	O
T18	I-Protein	1962	1963	1	1	I-NP	CD	O	23	NMOD	O
O	O	1964	1967	and	and	I-NP	CC	O	23	NMOD	O
T19	B-Protein	1968	1969	E	E	I-NP	NN	B-DNA	23	NMOD	B-DNA
T19	I-Protein	1969	1970	-	-	I-NP	HYPH	I-DNA	23	NMOD	I-DNA
T19	I-Protein	1970	1978	selectin	selectin	I-NP	NN	I-DNA	23	NMOD	I-DNA
O	O	1979	1983	gene	gene	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	1984	1992	exhibits	exhibit	B-VP	VBZ	O	4	SBAR	O
O	O	1993	1999	marked	marked	B-NP	JJ	O	26	NMOD	O
O	O	2000	2011	differences	difference	I-NP	NNS	O	24	OBJ	O
O	O	2012	2014	in	in	B-PP	IN	O	26	NMOD	O
O	O	2015	2020	redox	redox	B-NP	NN	O	29	NMOD	O
O	O	2021	2032	sensitivity	sensitivity	I-NP	NN	O	27	PMOD	O
O	O	2032	2033	,	,	O	,	O	24	P	O
O	O	2034	2042	allowing	allow	B-VP	VBG	O	24	VMOD	O
O	O	2043	2046	for	for	B-PP	IN	O	31	VMOD	O
O	O	2047	2059	differential	differential	B-NP	JJ	O	35	NMOD	O
O	O	2060	2064	gene	gene	I-NP	NN	O	35	NMOD	O
O	O	2065	2075	expression	expression	I-NP	NN	O	32	PMOD	O
O	O	2076	2085	regulated	regulate	B-VP	VBN	O	35	NMOD	O
O	O	2086	2088	by	by	B-PP	IN	O	36	VMOD	O
O	O	2089	2092	the	the	B-NP	DT	O	41	NMOD	O
O	O	2093	2097	same	same	I-NP	JJ	O	41	NMOD	O
O	O	2098	2111	transcription	transcription	I-NP	NN	B-protein	41	NMOD	B-protein
O	O	2112	2118	factor	factor	I-NP	NN	I-protein	37	PMOD	I-protein
O	O	2118	2119	.	.	O	.	O	3	P	O

O	O	2120	2123	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	2124	2128	data	datum	I-NP	NNS	O	4	SUB	O
O	O	2129	2133	also	also	B-ADVP	RB	O	4	VMOD	O
O	O	2134	2145	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	2146	2150	that	that	B-SBAR	IN	O	4	VMOD	O
T53	B-Entity	2151	2154	NAC	NAC	B-NP	NN	O	7	SUB	O
O	O	2155	2164	increases	increase	B-VP	VBZ	O	5	SBAR	O
O	O	2165	2168	the	the	B-NP	DT	O	9	NMOD	O
T54	B-Entity	2169	2172	GSH	GSH	I-NP	NN	O	7	OBJ	O
O	O	2172	2173	-	-	B-ADJP	HYPH	O	9	P	O
O	O	2173	2175	to	to	B-PP	TO	O	9	NMOD	O
O	O	2175	2176	-	-	B-NP	HYPH	O	14	NMOD	O
T55	B-Entity	2176	2180	GSSG	GSSG	I-NP	NN	O	14	NMOD	O
O	O	2181	2186	ratio	ratio	I-NP	NN	O	11	PMOD	O
O	O	2187	2193	within	within	B-PP	IN	O	14	NMOD	O
O	O	2194	2197	the	the	B-NP	DT	O	17	NMOD	O
O	O	2198	2200	EC	EC	I-NP	NNP	B-cell_type	15	PMOD	B-cell_type
O	O	2201	2211	suggesting	suggest	B-VP	VBG	O	4	VMOD	O
O	O	2212	2215	one	one	B-NP	CD	O	21	NMOD	O
O	O	2216	2224	possible	possible	I-NP	JJ	O	21	NMOD	O
O	O	2225	2234	mechanism	mechanism	I-NP	NN	O	18	OBJ	O
O	O	2235	2242	through	through	B-PP	IN	O	21	NMOD	O
O	O	2243	2248	which	which	B-NP	WDT	O	22	PMOD	O
O	O	2249	2253	this	this	B-NP	DT	O	25	NMOD	O
O	O	2254	2265	antioxidant	antioxidant	I-NP	NN	O	26	SUB	O
O	O	2266	2274	inhibits	inhibit	B-VP	VBZ	O	22	SBAR	O
O	O	2275	2282	agonist	agonist	B-NP	NN	O	31	NMOD	O
O	O	2282	2283	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	2283	2290	induced	induce	I-NP	VBN	O	31	NMOD	O
O	O	2291	2299	monocyte	monocyte	I-NP	NN	O	31	NMOD	O
O	O	2300	2308	adhesion	adhesion	I-NP	NN	O	26	OBJ	O
O	O	2309	2311	to	to	B-PP	TO	O	31	NMOD	O
O	O	2312	2314	EC	EC	B-NP	NN	B-cell_type	32	PMOD	B-cell_type
O	O	2314	2315	.	.	O	.	O	4	P	O
